[Treatment of refractory chronic circulatory insufficiency].
An analysis of archives material (1,500 case reports of patients with circulatory insufficiency) revealed that 200 patients (13%) had persistent, refractory circulatory failure. The revealed factors providing for the development of the refractoriness were: relapsing rheumocarditis, pneumonias, pulmonary infarctions in patients with rheumatic heart diseases, extended cicatrical changes in the myocardium of patients with atherosclerotic cardiosclerosis, or the underlying pathological process in cases of idiopathic myocardial lesions. These factors were taken into account, along with individualization of the therapeutic regimens of cardiac glycosides.
D000328:Adult; D000368:Aged; D001581:Benzothiadiazines; D002301:Cardiac Glycosides / Q000008:administration & dosage; D009202:Cardiomyopathies / Q000188:drug therapy*; D002908:Chronic Disease; D003327:Coronary Disease / Q000188:drug therapy*; D004232:Diuretics; D004338:Drug Combinations; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D012214:Rheumatic Heart Disease / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage; D013148:Spironolactone / Q000008:administration & dosage
D001581:Benzothiadiazines; D002301:Cardiac Glycosides; D004232:Diuretics; D004338:Drug Combinations; D049993:Sodium Chloride Symporter Inhibitors; D013148:Spironolactone; D005665:Furosemide
Lechenie bol'nykh s refrakternoĭ khronicheskoĭ nedostatochnost'iu krovoobrashcheniia